Selected Drugs Clear All
MultiCheck Results
- 1
Interaction
Monitor/Modify Tx |
||
|
Abrysvo
(respiratory syncytial virus vaccine (RSV)) + Tecvayli (teclistamab-cqyv)
(teclistamab) |
||
Monitor/Modify Txrespiratory syncytial virus vaccine + teclistamab if possible, vaccinate at least 2wk before starting teclistamab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects) |
||
Additional Considerations |
||
|
teclistamab
in Tecvayli (teclistamab-cqyv)
|
||
|
caution advised with narrow therapeutic index drugs, especially during teclistamab initiation/titration and up to 7 days after first full tx dose or during/after CRS; teclistamab may incr. cytokine release leading to suppression of metabolic enzymes, causing incr. drug levels, risk of adverse effects |
||